SEC Form 4 · accession 0000899243-17-018752
MyoKardia Inc · MYOK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jake Bauer
Officer — See Remarks
Period of report
Jul 20, 2017
Accepted (ET)
Jul 24, 2017 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001552451
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $13.90 | Jul 20, 2017 | A | 15,000 | A | — | Jul 19, 2027 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The shares subject to this option shall vest and become exercisable in two annual installments after the date of grant. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
Remarks
Senior Vice President, Finance and Corporate Development